Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Unresectable or Metastatic Sarcoma”

119 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 119 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT03141684
What this trial is testing

Testing Atezolizumab Alone or Atezolizumab Plus Bevacizumab in People With Advanced Alveolar Soft Part Sarcoma

Who this might be right for
Metastatic Alveolar Soft Part SarcomaUnresectable Alveolar Soft Part Sarcoma
National Cancer Institute (NCI) 63
Not applicableStudy completedNCT00253708
What this trial is testing

Massage Therapy in Treating the Symptoms of Patients With Locally Advanced or Metastatic Cancer

Who this might be right for
Cancer
Beth Israel Deaconess Medical Center 39
Testing effectiveness (Phase 2)Study completedNCT04076579
What this trial is testing

Trabectedin in Combination With Olaparib in Advanced Unresectable or Metastatic Sarcoma

Who this might be right for
SarcomaSarcoma Metastatic
University of Michigan Rogel Cancer Center 29
Large-scale testing (Phase 3)Study completedNCT02049905
What this trial is testing

Phase 3 Study to Treat Patients With Soft Tissue Sarcomas

Who this might be right for
Metastatic, Locally Advanced or Unresectable Soft Tissue Sarcoma
ImmunityBio, Inc. 433
Early research (Phase 1)Looking for participantsNCT06414434
What this trial is testing

BTX-A51 in Patients With Liposarcoma or CIC-rearranged Sarcoma

Who this might be right for
LiposarcomaRecurrent LiposarcomaMetastatic Liposarcoma+4 more
Michael Wagner, MD 24
Testing effectiveness (Phase 2)Study completedNCT00227669
What this trial is testing

Gemcitabine With or Without Docetaxel as Second-Line Therapy in Treating Patients With Metastatic or Relapsed, Unresectable Uterine or Soft Tissue Leiomyosarcoma

Who this might be right for
Sarcoma
UNICANCER 90
Testing effectiveness (Phase 2)Study completedNCT03433183
What this trial is testing

SARC031: MEK Inhibitor Selumetinib (AZD6244) in Combination With the mTOR Inhibitor Sirolimus for Patients With Malignant Peripheral Nerve Sheath Tumors

Who this might be right for
Malignant Peripheral Nerve Sheath TumorsNeurofibromatosis 1
Sarcoma Alliance for Research through Collaboration 21
Testing effectiveness (Phase 2)Active Not RecruitingNCT02243605
What this trial is testing

Cabozantinib S-malate in Treating Patients With Relapsed Osteosarcoma or Ewing Sarcoma

Who this might be right for
Metastatic Ewing SarcomaMetastatic OsteosarcomaRecurrent Ewing Sarcoma+7 more
National Cancer Institute (NCI) 90
Testing effectiveness (Phase 2)Looking for participantsNCT06571734
What this trial is testing

XL092 (Zanzalintinib) for the Treatment of Patients With Metastatic or Unresectable Leiomyosarcoma

Who this might be right for
Metastatic LeiomyosarcomaUnresectable Leiomyosarcoma
Northwestern University 29
Very early researchWithdrawnNCT04877587
What this trial is testing

Gemcitabine With Ascorbate Including Adolescents

Who this might be right for
Soft Tissue SarcomaBone SarcomaUnresectable Soft Tissue Sarcoma+3 more
David Dickens
Testing effectiveness (Phase 2)UnknownNCT00718484
What this trial is testing

Palifosfamide Tris Plus Doxorubicin Versus Doxorubicin in Unresectable or Metastatic Soft-tissue Sarcoma

Who this might be right for
Soft Tissue Sarcoma
Alaunos Therapeutics 67
Testing effectiveness (Phase 2)Ended earlyNCT01055028
What this trial is testing

Paclitaxel + Bevacizumab (Avastin) for the Treatment of Metastatic or Unresectable Angiosarcoma

Who this might be right for
AngiosarcomasSoft Tissue Sarcoma
Stanford University 18
Testing effectiveness (Phase 2)Ended earlyNCT03468075
What this trial is testing

Gemcitabine Plus Ascorbate for Sarcoma in Adults

Who this might be right for
SarcomaSoft Tissue SarcomaUnresectable Soft Tissue Sarcoma+2 more
Mohammed Milhem, MBBS 10
Testing effectiveness (Phase 2)Study completedNCT02448537
What this trial is testing

A Phase II Multi-Strata Study of PM01183 as a Single Agent or in Combination With Conventional Chemotherapy in Metastatic and/or Unresectable Sarcomas

Who this might be right for
Metastatic Sarcoma
Massachusetts General Hospital 42
Early research (Phase 1)Ended earlyNCT04627142
What this trial is testing

Test Different Doses of BI 1701963 in Combination With Irinotecan in People With Advanced Bowel Cancer With Kirsten Rat Sarcoma Viral Oncogene Homologue (KRAS) Mutation

Who this might be right for
Metastatic Colorectal Cancer (CRC)
Boehringer Ingelheim 15
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06384248
What this trial is testing

Phase II Clinical Study of LTC004 in Patients With Advanced Sarcoma

Who this might be right for
Unresectable or Metastatic Sarcoma
Letolab 30
Large-scale testing (Phase 3)WithdrawnNCT03342300
What this trial is testing

Pegylated Liposomal Doxorubicin Versus Pirarubicin Plus Ifosfamide, Dacarbazine in Locally Advanced, Unresectable or Metastatic Soft-tissue Sarcoma

Who this might be right for
Progression-free SurvivalOverall SurvivalToxicity
Peking University People's Hospital
Early research (Phase 1)Study completedNCT03126591
What this trial is testing

Olaratumab (LY3012207) Plus Pembrolizumab in Participants With Advanced or Metastatic Soft Tissue Sarcoma

Who this might be right for
Soft Tissue Sarcoma
Eli Lilly and Company 41
Not applicableLooking for participantsNCT05868629
What this trial is testing

Clinical Study To Further Evaluate The Efficacy Of Dabrafenib Plus Trametinib In Patients With Rare BRAF V600E Mutation-Positive Unresectable or Metastatic Solid Tumors

Who this might be right for
Rare Unresectable or Metastatic BRAF V600E Mutation-positive Solid Tumors
Novartis Pharmaceuticals 40
Testing effectiveness (Phase 2)Ended earlyNCT03074318
What this trial is testing

Avelumab and Trabectedin in Treating Patients With Liposarcoma or Leiomyosarcoma That is Metastatic or Cannot Be Removed by Surgery

Who this might be right for
Metastatic LeiomyosarcomaMetastatic LiposarcomaUnresectable Leiomyosarcoma+1 more
Fred Hutchinson Cancer Center 35
Load More Results